East of England

‘AstraZeneca effect’ is shot in arm for Cambridge

By 29 November 2013

Cambridge pipeline

The news that Anglo-Swedish pharmaceutical company AstraZeneca has appointed the architect behind London’s Tate Modern gallery to transform the biomedical campus near Addenbrooke’s Hospital, Cambridge, into its national headquarters, ends months of speculation about the size of the scheme.

This content is only available to registered users

You must be logged in to continue

Gated access promo

Would you like to read more?

Try Property Week For Free to finish this article.

Sign up now for the following benefits:

  • Unlimited access to Property Week
  • Breaking news, comment and analysis from industry experts as it happens
  • Choose from our portfolio of email newsletters

To access this article TRY FOR FREE NOW

Don’t want full access? REGISTER NOW to read this article and up to 3 more this month and subscribe to our newsletters.

Registered users and subscribers SIGN IN here to continue